IDH1 and cancer: Interestingly, IDH mutations or the epigenetic effect of 2-HG can decrease the level of NAD+, and inhibiting nicotinamide phosphoribosyltransferase (NAMPT) can induce cytotoxicity in endogenous IDH1/2-mutant cancer cells [116].